Clarity News article

Media Release: Clarity Pharmaceuticals raises $1.1 million

1 May 2014 Oversubscribed Aussie startup set to deliver new personalised medicine Sydney, Australia, 1 May 2014 – Sydney based biotech startup Clarity Pharmaceuticals has raised $1.1 million from investors to expand its international operations in the US, Europe and Asia and to develop new personalised medicine applications for their proprietary pharmaceutical imaging technology. Sydney…

Clarity News article

New Executive Chairman

18 November 2013   Clarity Pharmaceuticals (Clarity), a Sydney-based companion diagnostic and personalised medicine company, is pleased to announce the appointment of Dr Alan Taylor as its new Executive Chairman to the Board. Dr Taylor has a background in both investment banking and medical science, and brings a wealth of experience to the Clarity Board.…

Clarity News article

Clarity Pharmaceuticals awarded $300,000 in Commercialisation Australia Grant funding

5 December 2011 Clarity Pharmaceuticals has been awarded two Commercialisation Australia grants totalling $300,000.  The “Skills and Knowledge” and “Proof of Concept” grants will help Clarity provide its PET imaging agents and services for human clinical studies, and aid in Clarity’s diagnostic development program.  The funding will directly contribute to a clinical trial validating one…

Clarity News article

Dalton Pharma Services and Clarity Pharmaceuticals Enter Into Manufacturing Services Agreement

30 July 2012 Dalton Pharma Services, a leading provider of development and manufacturing services to pharmaceutical companies, today announced the Company has entered into a Manufacturing Services Agreement with Clarity Pharmaceuticals based in Sydney, Australia. Clarity is a specialty radiopharmaceutical company dedicated to the development of clinical tools for PET imaging and companion diagnostics. Dalton Pharma Services will…